No Detail Found!

New dynamic scoring method for deep evaluation of naloxegol as B-tubulin binding inhibitor

Author(s)
Hamdullah Khadim Sheikh Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi; *BioLab, Instituto Universitario de Bio-Orgénica Antonio Gonzalez (IUBO-AG), Universidad de La Laguna, San Cristobal de La Laguna, Spain
Jose M Padron BioLab, Instituto Universitario de Bio-Orgénica Antonio Gonzalez (IUBO-AG), Universidad de La Laguna, San Cristobal de La Laguna, Spain
Tanzila Arshad Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan
Uzma Habib School of Interdisciplinary Engineering and Sciences (SINES), National University of Sciences and Technology (NUST), Islamabad, Pakistan
Shahnila Jamil Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan
Haroon Khan Department of Pharmacy, Abdul Wali Khan University, Mardan, Pakistan
Khurshid Ayub SDepartment of Chemistry, COMSATS University, Islamabad, Pakistan
Abstract
We report a new scoring method for rating the performance of ligands on same protein, using their extensive dynamic flexibility properties, binding with protein and impact on receptor protein. Based on molecular dynamics (MD), this method is more accurate than single-point energy calculations. This method identified an ideal FDA-approved drug as B-tubulin microtubule inhibitor with improved attributes compared to commercial microtubule disassembly inhibitor, Paclitaxel (PTX). We started with virtual screening (VS) of FDA-approved drugs inside PTX s binding pocket (A) of human B-tubulin protein. Screened ligands (>80% score) were evaluated for non-permeation through blood-brain barrier (BBB) as targets were body cancers, gastrointestinal absorption, Lipinski, non-efflux from central nervous system (CNS) by p-glycoprotein (Pgp) and ADMET analysis. This identified FDA-approved Naloxegol drug with superior attributes compared to PTX. Pocket (A) specific docking of chain length variable derivatives of Naloxegol gave docked poses that underwent MD run to give a range of properties and their descriptors (RMSD, RMSF, RoG, H-bonds, hydrophobic interaction, and SASA). QSPR validated that MD properties dependent upon [-CH»-CHj-O-]u=0.7 chain length of Naloxegol. MD data underwent normalization, PCA analysis, and scoring against PTX. One Naloxegol derivative scored higher than PTX as a potential microtubule disassembly inhibitor.
Publication Details
Page(s) 949-959
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 5, Year: 2024

Request the full text from PASTIC

Keywords
Paclitaxel, ADMET, Molecular Dynamics Simulations, QSPR modeling., Computer-aided drug design, p-tubulin
0

Citations

0

Downloads

66

Views